-
1
-
-
0032933622
-
Taxol suppresses dynamics of individual microtubules in living human tumor cells
-
Yvon A.M., Wadsworth P., Jordan M.A. Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol. Biol. Cell 1999, 10(4):947-959.
-
(1999)
Mol. Biol. Cell
, vol.10
, Issue.4
, pp. 947-959
-
-
Yvon, A.M.1
Wadsworth, P.2
Jordan, M.A.3
-
2
-
-
28144445570
-
Docetaxel: a review of its use in metastatic breast cancer
-
Lyseng-Williamson K.A., Fenton C. Docetaxel: a review of its use in metastatic breast cancer. Drugs 2005, 65(17):2513-2531.
-
(2005)
Drugs
, vol.65
, Issue.17
, pp. 2513-2531
-
-
Lyseng-Williamson, K.A.1
Fenton, C.2
-
3
-
-
3142752689
-
Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel
-
Hopper-Borge E., Chen Z.S., Shchaveleva I., Belinsky M.G., Kruh G.D. Analysis of the drug resistance profile of multidrug resistance protein 7 (ABCC10): resistance to docetaxel. Cancer Res. 2004, 64(14):4927-4930.
-
(2004)
Cancer Res.
, vol.64
, Issue.14
, pp. 4927-4930
-
-
Hopper-Borge, E.1
Chen, Z.S.2
Shchaveleva, I.3
Belinsky, M.G.4
Kruh, G.D.5
-
4
-
-
41949114548
-
Microtubules and chemoresistant breast cancer
-
McGrogan B.T., Gilmartin B., Carney D.N., McCann A., Taxanes Microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta. 2008, 1785(2):96-132.
-
(2008)
Biochim. Biophys. Acta.
, vol.1785
, Issue.2
, pp. 96-132
-
-
McGrogan, B.T.1
Gilmartin, B.2
Carney, D.N.3
McCann, A.4
-
5
-
-
77649191871
-
Microtubules and resistance to tubulin-binding agents
-
Kavallaris M. Microtubules and resistance to tubulin-binding agents. Nat. Rev. Cancer 2010, 10(3):194-204.
-
(2010)
Nat. Rev. Cancer
, vol.10
, Issue.3
, pp. 194-204
-
-
Kavallaris, M.1
-
6
-
-
33846471634
-
Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers
-
Ooe A., Kato K., Noguchi S. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers. Breast Cancer Res. Treat. 2007, 101(3):305-315.
-
(2007)
Breast Cancer Res. Treat.
, vol.101
, Issue.3
, pp. 305-315
-
-
Ooe, A.1
Kato, K.2
Noguchi, S.3
-
7
-
-
4644224824
-
Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells
-
Brown I., Shalli K., McDonald S.L., Moir S.E., Hutcheon A.W., Heys S.D., Schofield A.C. Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells. Breast Cancer Res. 2004, 6(5):R601-607.
-
(2004)
Breast Cancer Res.
, vol.6
, Issue.5
-
-
Brown, I.1
Shalli, K.2
McDonald, S.L.3
Moir, S.E.4
Hutcheon, A.W.5
Heys, S.D.6
Schofield, A.C.7
-
8
-
-
33645294070
-
Oncomirs - microRNAs with a role in cancer
-
Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6(4):259-269.
-
(2006)
Nat. Rev. Cancer
, vol.6
, Issue.4
, pp. 259-269
-
-
Esquela-Kerscher, A.1
Slack, F.J.2
-
9
-
-
33846188098
-
MicroRNAs as oncogenes and tumor suppressors
-
Zhang B., Pan X., Cobb G.P., Anderson T.A. MicroRNAs as oncogenes and tumor suppressors. Dev. Bio. 2007, 302(1):1-12.
-
(2007)
Dev. Bio.
, vol.302
, Issue.1
, pp. 1-12
-
-
Zhang, B.1
Pan, X.2
Cobb, G.P.3
Anderson, T.A.4
-
10
-
-
34250697605
-
MicroRNA expression profiles for the NCI-60 cancer cell panel
-
Blower P.E., Verducci J.S., Lin S., Zhou J., Chung J.H., Dai Z., Liu C.G., Reinhold W., Lorenzi P.L., Kaldjian E.P., Croce C.M., Weinstein J.N., Sadee W. MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol. Cancer Ther. 2007, 6(5):1483-1491.
-
(2007)
Mol. Cancer Ther.
, vol.6
, Issue.5
, pp. 1483-1491
-
-
Blower, P.E.1
Verducci, J.S.2
Lin, S.3
Zhou, J.4
Chung, J.H.5
Dai, Z.6
Liu, C.G.7
Reinhold, W.8
Lorenzi, P.L.9
Kaldjian, E.P.10
Croce, C.M.11
Weinstein, J.N.12
Sadee, W.13
-
11
-
-
77955619456
-
MiR-181b Modulates multidrug resistance by targeting BCL2 in human cancer cell lines
-
Zhu W., Shan X., Wang T., Shu Y., Liu P. miR-181b Modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J. Cancer 2010, 127(1):2520-2529.
-
(2010)
Int. J. Cancer
, vol.127
, Issue.1
, pp. 2520-2529
-
-
Zhu, W.1
Shan, X.2
Wang, T.3
Shu, Y.4
Liu, P.5
-
12
-
-
77955478900
-
MiR-192/miR-215 Influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation
-
Boni V., Bitarte N., Cristobal I., Zarate R., Rodriguez J., Maiello E., Garcia-Foncillas J., Bandres E. miR-192/miR-215 Influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol. Cancer Ther. 2010, 9(8):2265-2275.
-
(2010)
Mol. Cancer Ther.
, vol.9
, Issue.8
, pp. 2265-2275
-
-
Boni, V.1
Bitarte, N.2
Cristobal, I.3
Zarate, R.4
Rodriguez, J.5
Maiello, E.6
Garcia-Foncillas, J.7
Bandres, E.8
-
13
-
-
66849113786
-
MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells
-
Pan Y.Z., Morris M.E., Yu A.M. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol. Pharmacol. 2009, 75(6):1374-1379.
-
(2009)
Mol. Pharmacol.
, vol.75
, Issue.6
, pp. 1374-1379
-
-
Pan, Y.Z.1
Morris, M.E.2
Yu, A.M.3
-
14
-
-
77949904204
-
Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer
-
Shi W., Alajez N.M., Bastianutto C., Hui A.B., Mocanu J.D., Ito E., Busson P., Lo K.W., Ng R., Waldron J., O'Sullivan B., Liu F.F. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int. J. Cancer 2010, 126(9):2036-2048.
-
(2010)
Int. J. Cancer
, vol.126
, Issue.9
, pp. 2036-2048
-
-
Shi, W.1
Alajez, N.M.2
Bastianutto, C.3
Hui, A.B.4
Mocanu, J.D.5
Ito, E.6
Busson, P.7
Lo, K.W.8
Ng, R.9
Waldron, J.10
O'Sullivan, B.11
Liu, F.F.12
-
15
-
-
79955889222
-
MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance
-
Dai Y., Xie C.H., Neis J.P., Fan C.Y., Vural E., Spring P.M. MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance. Head Neck 2011, 33(6):786-791.
-
(2011)
Head Neck
, vol.33
, Issue.6
, pp. 786-791
-
-
Dai, Y.1
Xie, C.H.2
Neis, J.P.3
Fan, C.Y.4
Vural, E.5
Spring, P.M.6
-
16
-
-
77951945516
-
Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1)
-
Rui W., Bing F., Hai-Zhu S., Wei D., Long-Bang C. Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1). J. Cell Mol. Med. 2010, 14(1-2):206-214.
-
(2010)
J. Cell Mol. Med.
, vol.14
, Issue.1-2
, pp. 206-214
-
-
Rui, W.1
Bing, F.2
Hai-Zhu, S.3
Wei, D.4
Long-Bang, C.5
-
17
-
-
68949159920
-
Mechanism of drug resistance identified in human lung adenocarcinoma cell line SPC-A1 selected for resistance to docetaxel
-
Hai S., Long-Bang C. Mechanism of drug resistance identified in human lung adenocarcinoma cell line SPC-A1 selected for resistance to docetaxel. Chin. J. Cancer Res. 2009, 21(3):207-216.
-
(2009)
Chin. J. Cancer Res.
, vol.21
, Issue.3
, pp. 207-216
-
-
Hai, S.1
Long-Bang, C.2
-
18
-
-
66749160812
-
The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras
-
Tsang W.P., Kwok T.T. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis 2009, 30(6):953-959.
-
(2009)
Carcinogenesis
, vol.30
, Issue.6
, pp. 953-959
-
-
Tsang, W.P.1
Kwok, T.T.2
-
19
-
-
0034040624
-
The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity
-
Yang F., Sarangarajan R., Le Poole I.C., Medrano E.E., Boissy R.E. The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J. Invest. Dermatol. 2000, 114(1):157-164.
-
(2000)
J. Invest. Dermatol.
, vol.114
, Issue.1
, pp. 157-164
-
-
Yang, F.1
Sarangarajan, R.2
Le Poole, I.C.3
Medrano, E.E.4
Boissy, R.E.5
-
20
-
-
27644488740
-
Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo
-
Zhang S.Z., Pan F.Y., Xu J.F., Yuan J., Guo S.Y., Dai G., Xue B., Shen W.G., Wen C.J., Zhao D.H., Li C.J. Knockdown of c-Met by adenovirus-delivered small interfering RNA inhibits hepatocellular carcinoma growth in vitro and in vivo. Mol. Cancer Ther. 2005, 4(10):1577-1584.
-
(2005)
Mol. Cancer Ther.
, vol.4
, Issue.10
, pp. 1577-1584
-
-
Zhang, S.Z.1
Pan, F.Y.2
Xu, J.F.3
Yuan, J.4
Guo, S.Y.5
Dai, G.6
Xue, B.7
Shen, W.G.8
Wen, C.J.9
Zhao, D.H.10
Li, C.J.11
-
21
-
-
60849131758
-
The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo
-
Liu P., Chen L., Huang X. The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo. Cancer Biother. Radiopharm. 2009, 24(1):91-98.
-
(2009)
Cancer Biother. Radiopharm.
, vol.24
, Issue.1
, pp. 91-98
-
-
Liu, P.1
Chen, L.2
Huang, X.3
-
22
-
-
27644526912
-
Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer
-
Hu Z., Lin D., Yuan J., Xiao T., Zhang H., Sun W., Han N., Ma Y., Di X., Gao M., Ma J., Zhang J., Cheng S., Gao Y. Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer. Clin. Cancer Res. 2005, 11(13):4646-4652.
-
(2005)
Clin. Cancer Res.
, vol.11
, Issue.13
, pp. 4646-4652
-
-
Hu, Z.1
Lin, D.2
Yuan, J.3
Xiao, T.4
Zhang, H.5
Sun, W.6
Han, N.7
Ma, Y.8
Di, X.9
Gao, M.10
Ma, J.11
Zhang, J.12
Cheng, S.13
Gao, Y.14
-
23
-
-
0034212385
-
Paclitaxel-induced cell death: where the cell cycle and apoptosis come together
-
Wang T.H., Wang H.S., Soong Y.K. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 2000, 88(11):2619-2628.
-
(2000)
Cancer
, vol.88
, Issue.11
, pp. 2619-2628
-
-
Wang, T.H.1
Wang, H.S.2
Soong, Y.K.3
-
24
-
-
0036902234
-
Regulation of APC-Cdc20 by the spindle checkpoint
-
Yu H. Regulation of APC-Cdc20 by the spindle checkpoint. Curr. Opin. Cell Biol. 2002, 14(6):706-714.
-
(2002)
Curr. Opin. Cell Biol.
, vol.14
, Issue.6
, pp. 706-714
-
-
Yu, H.1
-
25
-
-
20044390359
-
Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients
-
Chang J.C., Wooten E.C., Tsimelzon A., Hilsenbeck S.G., Gutierrez M.C., Tham Y.L., Kalidas M., Elledge R., Mohsin S., Osborne C.K., Chamness G.C., Allred D.C., Lewis M.T., Wong H., O'Connell P. Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients. J. Clin. Oncol. 2005, 23(6):1169-1177.
-
(2005)
J. Clin. Oncol.
, vol.23
, Issue.6
, pp. 1169-1177
-
-
Chang, J.C.1
Wooten, E.C.2
Tsimelzon, A.3
Hilsenbeck, S.G.4
Gutierrez, M.C.5
Tham, Y.L.6
Kalidas, M.7
Elledge, R.8
Mohsin, S.9
Osborne, C.K.10
Chamness, G.C.11
Allred, D.C.12
Lewis, M.T.13
Wong, H.14
O'Connell, P.15
-
26
-
-
77950395080
-
Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells
-
Kastl L., Brown I., Schofield A.C. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells. Int. J. Oncol. 2010, 36(5):1235-1241.
-
(2010)
Int. J. Oncol.
, vol.36
, Issue.5
, pp. 1235-1241
-
-
Kastl, L.1
Brown, I.2
Schofield, A.C.3
-
27
-
-
0029079267
-
Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function
-
Golsteyn R.M., Mundt K.E., Fry A.M., Nigg E.A. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J. Cell Biol. 1995, 129(6):1617-1628.
-
(1995)
J. Cell Biol.
, vol.129
, Issue.6
, pp. 1617-1628
-
-
Golsteyn, R.M.1
Mundt, K.E.2
Fry, A.M.3
Nigg, E.A.4
-
28
-
-
0036256260
-
Plk1 promotes nuclear translocation of human Cdc25C during prophase
-
Toyoshima-Morimoto F., Taniguchi E., Nishida E. Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep. 2002, 3(4):341-348.
-
(2002)
EMBO Rep.
, vol.3
, Issue.4
, pp. 341-348
-
-
Toyoshima-Morimoto, F.1
Taniguchi, E.2
Nishida, E.3
-
29
-
-
0035826154
-
Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase
-
Toyoshima-Morimoto F., Taniguchi E., Shinya N., Iwamatsu A., Nishida E. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature 2001, 410(6825):215-220.
-
(2001)
Nature
, vol.410
, Issue.6825
, pp. 215-220
-
-
Toyoshima-Morimoto, F.1
Taniguchi, E.2
Shinya, N.3
Iwamatsu, A.4
Nishida, E.5
-
30
-
-
62849123093
-
Polo-like kinases: conservation and divergence in their functions and regulation
-
Archambault V., Glover D.M. Polo-like kinases: conservation and divergence in their functions and regulation. Nat. Rev. Mol. Cell Biol. 2009, 10(4):265-275.
-
(2009)
Nat. Rev. Mol. Cell Biol.
, vol.10
, Issue.4
, pp. 265-275
-
-
Archambault, V.1
Glover, D.M.2
-
31
-
-
13244269808
-
Polo-like kinases and oncogenesis
-
Eckerdt F., Yuan J., Strebhardt K. Polo-like kinases and oncogenesis. Oncogene 2005, 24(2):267-276.
-
(2005)
Oncogene
, vol.24
, Issue.2
, pp. 267-276
-
-
Eckerdt, F.1
Yuan, J.2
Strebhardt, K.3
-
32
-
-
0031051218
-
Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer
-
Wolf G., Elez R., Doermer A., Holtrich U., Ackermann H., Stutte H.J., Altmannsberger H.M., Rübsamen-Waigmann H., Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 1997, 14(5):543-549.
-
(1997)
Oncogene
, vol.14
, Issue.5
, pp. 543-549
-
-
Wolf, G.1
Elez, R.2
Doermer, A.3
Holtrich, U.4
Ackermann, H.5
Stutte, H.J.6
Altmannsberger, H.M.7
Rübsamen-Waigmann, H.8
Strebhardt, K.9
-
33
-
-
77955167321
-
Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
-
Strebhardt K. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat. Rev. Drug Discov. 2010, 9(8):643-660.
-
(2010)
Nat. Rev. Drug Discov.
, vol.9
, Issue.8
, pp. 643-660
-
-
Strebhardt, K.1
-
34
-
-
4344718620
-
Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis
-
van Vugt M.A., van de Weerdt B.C., Vader G., Janssen H., Calafat J., Klompmaker R., Wolthuis R.M., Medema R.H. Polo-like kinase-1 is required for bipolar spindle formation but is dispensable for anaphase promoting complex/Cdc20 activation and initiation of cytokinesis. J. Biol. Chem. 2004, 279(35):36841-36854.
-
(2004)
J. Biol. Chem.
, vol.279
, Issue.35
, pp. 36841-36854
-
-
van Vugt, M.A.1
van de Weerdt, B.C.2
Vader, G.3
Janssen, H.4
Calafat, J.5
Klompmaker, R.6
Wolthuis, R.M.7
Medema, R.H.8
-
35
-
-
4644266184
-
Roles of polo-like kinase 1 in the assembly of functional mitotic spindles
-
Sumara I., Giménez-Abián J.F., Gerlich D., Hirota T., Kraft C., delaTorre C., Ellenberg J., Peters J.M. Roles of polo-like kinase 1 in the assembly of functional mitotic spindles. Curr. Biol. 2004, 14(19):1712-1722.
-
(2004)
Curr. Biol.
, vol.14
, Issue.19
, pp. 1712-1722
-
-
Sumara, I.1
Giménez-Abián, J.F.2
Gerlich, D.3
Hirota, T.4
Kraft, C.5
delaTorre, C.6
Ellenberg, J.7
Peters, J.M.8
-
36
-
-
33750227695
-
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance
-
McInnes C., Mazumdar A., Mezna M., Meades C., Midgley C., Scaerou F., Carpenter L., Mackenzie M., Taylor P., Walkinshaw M., Fischer P.M., Glover D. Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. Nat. Chem. Biol. 2006, 2(11):608-617.
-
(2006)
Nat. Chem. Biol.
, vol.2
, Issue.11
, pp. 608-617
-
-
McInnes, C.1
Mazumdar, A.2
Mezna, M.3
Meades, C.4
Midgley, C.5
Scaerou, F.6
Carpenter, L.7
Mackenzie, M.8
Taylor, P.9
Walkinshaw, M.10
Fischer, P.M.11
Glover, D.12
-
37
-
-
33846931644
-
The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1
-
Lénárt P., Petronczki M., Steegmaier M., Di Fiore B., Lipp J.J., Hoffmann M., Rettig W.J., Kraut N., Peters J.M. The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1. Curr. Biol. 2007, 17(4):304-315.
-
(2007)
Curr. Biol.
, vol.17
, Issue.4
, pp. 304-315
-
-
Lénárt, P.1
Petronczki, M.2
Steegmaier, M.3
Di Fiore, B.4
Lipp, J.J.5
Hoffmann, M.6
Rettig, W.J.7
Kraut, N.8
Peters, J.M.9
-
38
-
-
70350348676
-
The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
-
Zhang Y., Liu Y., Yang Y.X., Xia J.H., Zhang H.X., Li H.B., Yu C.Z. The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity. J. Exp. Clin. Cancer Res. 2009, 28(1):130.
-
(2009)
J. Exp. Clin. Cancer Res.
, vol.28
, Issue.1
, pp. 130
-
-
Zhang, Y.1
Liu, Y.2
Yang, Y.X.3
Xia, J.H.4
Zhang, H.X.5
Li, H.B.6
Yu, C.Z.7
-
39
-
-
33646551185
-
Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells
-
Schmidt M., Hofmann H.P., Sanders K., Sczakiel G., Beckers T.L., Gekeler V. Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells. Mol. Cancer Ther. 2006, 5(4):809-817.
-
(2006)
Mol. Cancer Ther.
, vol.5
, Issue.4
, pp. 809-817
-
-
Schmidt, M.1
Hofmann, H.P.2
Sanders, K.3
Sczakiel, G.4
Beckers, T.L.5
Gekeler, V.6
-
40
-
-
34548183782
-
Rational combinations of siRNAs targeting Plk1 with breast cancer drugs enhanced drug sensitivity by Plk1-specific siRNA
-
Spänkuch B., Kurunci-Csacsko E., Kaufmann M., Strebhardt K. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs enhanced drug sensitivity by Plk1-specific siRNA. Oncogene 2007, 26(39):5793-5807.
-
(2007)
Oncogene
, vol.26
, Issue.39
, pp. 5793-5807
-
-
Spänkuch, B.1
Kurunci-Csacsko, E.2
Kaufmann, M.3
Strebhardt, K.4
-
41
-
-
79951914745
-
Simultaneous delivery of siRNA and paclitaxel via a two-in-one micelleplex promotes synergistic tumor suppression
-
Sun T.M., Du J.Z., Yao Y.D., Mao C.Q., Dou S., Huang S.Y., Zhang P.Z., Leong K.W., Song E.W., Wang J. Simultaneous delivery of siRNA and paclitaxel via a two-in-one micelleplex promotes synergistic tumor suppression. ACS Nano. 2011, 5(2):1483-1494.
-
(2011)
ACS Nano.
, vol.5
, Issue.2
, pp. 1483-1494
-
-
Sun, T.M.1
Du, J.Z.2
Yao, Y.D.3
Mao, C.Q.4
Dou, S.5
Huang, S.Y.6
Zhang, P.Z.7
Leong, K.W.8
Song, E.W.9
Wang, J.10
|